Real reason behind rupee's pain; Why trade war is still the biggest risk, and other top stories of the day

To keep you updated, we send ET Markets Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

DAILY BRIEF Wed, Aug 15, 2018 #ValueInvestor#IPOs#Q1Results#CrudeOil#ExpertViews SENSEX 37852.00 207.10 NIFTY 50 11435.10 79.35 Gold 29732.00 7.00 USD/INR 69.90 -0.03

TOP OF THE DAY Nifty50 to trade in broad range; chase momentum selectively Thursday will see the levels of 11,470 and 11,495 playing out as immediate resistance area. Why even a non-major Turkish lira is hitting rupee really hard Comfortable forex reserves to deal with rupee volatility: Jaitley Will Sun Pharma get its mojo back on Dalal Street? Blackstone may pick stake in Jet Airways' loyalty arm RBI dismisses Kotak Mahindra Bank's plan to dilute promoter stake Freedom fighters can tell you a lot on finances

Top Gainers NSE 5 companies (largecap) appreciated more than 5% Balkrishna Ind. 8.72% Sun Pharma 6.72% More from Gainers Top Losers NSE 2 companies (largecap) price decreased more than -3% Cadila Health -4.05% Abbott India -3.25% More from Losers 52 Week High NSE 31 companies touched new 52-week high today Lincoln Pharma 13.92% Albert David 8.05% More from 52 Week High

AdvertorialFalse income tax refund claims could attract these penalties The income tax department has recently claimed to have busted a racket of fraudulent claim of tax refunds by employees of well known companies. AdvertorialAutomating job skills matching using Artificial Intelligence Finding the right candidates and matching them with the right role is at the core of HR, but it's beyond human capacity to do this without an error, merely on the basis of an individual's resume.

Warren Buffett's boosts Goldman, Teva stakes; buys more Apple The changes were disclosed on Tuesday in a filing detailing Berkshire's US-listed holdings. BSE to launch liquidity enhancement plan on single stock options Trade war still the biggest tail risk: BofAML survey GST benefits prompt firms to absorb unlisted units

Market moguls Podcast Video Nifty at new highs, but enough good reasons to call it a mirage ETMarkets Evening Podcast: Stocks back in black; should you stay put? RBI rejects Kotak Bk's stake dilution plan

RECOMMENDATIONS State Bank of India Overweight State Bank of India, target Rs 425: Morgan Stanley Overweight NCC Ltd. Buy NCC, target Rs 165: Phillip Capital (India) Buy GAIL (India) Ltd. Buy GAIL (India), target Rs 435: CLSA Buy Dr. Lal Pathlabs Ltd. Buy Dr. Lal Pathlabs, target Rs 1,320: CLSA Buy Pidilite Industries Ltd. Buy Pidilite Industries, target Rs 1166: Kunal Bothra Buy

Turkish troubles unlikely to aggravate EM worries After initial panic over Turkey's meltdown eased, investors were seen looking for buying opportunities as EM v... July sees 11 PE exits worth $376 million: EY Banks finalising power firms' debt resolution plans Gold hits 18-month low as dollar flares on Turkey woes

Quick Links Markets Live | Market Stats | IPOs | Technicals | Commodities | Forex

About us|Advertise with us|Feedback|Sitemap|Code of Ethics More Newsletters: Daily Newsletter | Markets Morning | ET Investment Opportunities | Wealth | View all © Times Internet Limited. To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here, To unsubscribe or edit your subscriptions please click here